Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial

Abstract Background Most breast cancers are detected at an early stage in which case conservative surgery is indicated. An accurate preoperative localization technique is essential for conservative surgery of non-palpable breast lesions. Currently, the gold standard technique is wire localization (W...

Full description

Saved in:
Bibliographic Details
Main Authors: Raphaël Pete, Céleste Pinard, Fanny Sirodot, Ioana Molnar, Margot Dressaire, Angeline Ginzac, Catherine Abrial, Xavier Durando, Marielle Tekath
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-13453-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585658150944768
author Raphaël Pete
Céleste Pinard
Fanny Sirodot
Ioana Molnar
Margot Dressaire
Angeline Ginzac
Catherine Abrial
Xavier Durando
Marielle Tekath
author_facet Raphaël Pete
Céleste Pinard
Fanny Sirodot
Ioana Molnar
Margot Dressaire
Angeline Ginzac
Catherine Abrial
Xavier Durando
Marielle Tekath
author_sort Raphaël Pete
collection DOAJ
description Abstract Background Most breast cancers are detected at an early stage in which case conservative surgery is indicated. An accurate preoperative localization technique is essential for conservative surgery of non-palpable breast lesions. Currently, the gold standard technique is wire localization (WL). However, this technique has well-known drawbacks. Several wire-free techniques have been developed to overcome these drawbacks; one technique is localisation by Radiofrequency Identification (RFID). The purpose of this clinical trial was to assess the superiority of RFID tags (HOLOGIC) in terms of patient satisfaction, over wire localization of non-palpable breast lesions. Methods This was a single-centre, prospective, controlled and non-interventional trial. Patients were followed from their inclusion at the time of the preoperative consultation to the postoperative consultation, one month after surgery. Data on anxiety and satisfaction was collected from patients and clinicians using questionnaires, and clinical data was collected from the medical files. The primary outcome was the patients’ satisfaction scores, assessed using a visual analogue scale. Results Eighty patients were sequentially enrolled in two groups: the wire group (n = 40) and the RFID group (n = 40). One patient from the RFID group was excluded from the analysis because of a substantial migration during deployment. On a 10-point Visual Analogue Scale, the patients’ median satisfaction score was 9.8 (IQR = 1.32) for the wire group and 10 (IQR = 0.07) for the RFID group (p < 0.001). A reduction in pain between device insertion and surgery was observed in the RFID group (p = 0.009). The median placement time was shorter in the RFID group (15 min, IQR = 6) than in the wire group (20 min, IQR = 30) (p = 0.01). Conclusion Our results show a statistically significant difference in median patient satisfaction score with the localization of non-palpable breast cancer lesions using RFID tags compared to the use of the WL. Although our results did not show clinically significant outcomes in terms of satisfaction, RFID tags are a reliable alternative to WL and simplify the organization of patients’ healthcare trajectories. Trial registration ClinicalTrials.gov ID; NCT04750889 registered on February 11, 2021. https://clinicaltrials.gov/ct2/show/NCT04750889?term=rfid&draw=2&rank=1
format Article
id doaj-art-ae0589c069984985bf0a7ff2ac6fc272
institution Kabale University
issn 1471-2407
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-ae0589c069984985bf0a7ff2ac6fc2722025-01-26T12:37:58ZengBMCBMC Cancer1471-24072025-01-0125111010.1186/s12885-025-13453-0Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trialRaphaël Pete0Céleste Pinard1Fanny Sirodot2Ioana Molnar3Margot Dressaire4Angeline Ginzac5Catherine Abrial6Xavier Durando7Marielle Tekath8Unité de Sénologie, Centre Jean PERRINDivision de Recherche Clinique, Délégation Recherche Clinique & Innovation, Centre Jean PERRIN Division de Recherche CliniqueService de chirurgie oncologique, Centre Jean PERRINDivision de Recherche Clinique, Délégation Recherche Clinique & Innovation, Centre Jean PERRIN Division de Recherche CliniqueService de Radiologie, Centre Hospitalier UniversitaireDivision de Recherche Clinique, Délégation Recherche Clinique & Innovation, Centre Jean PERRIN Division de Recherche CliniqueDivision de Recherche Clinique, Délégation Recherche Clinique & Innovation, Centre Jean PERRIN Division de Recherche CliniqueDivision de Recherche Clinique, Délégation Recherche Clinique & Innovation, Centre Jean PERRIN Division de Recherche CliniqueUnité de Sénologie, Centre Jean PERRINAbstract Background Most breast cancers are detected at an early stage in which case conservative surgery is indicated. An accurate preoperative localization technique is essential for conservative surgery of non-palpable breast lesions. Currently, the gold standard technique is wire localization (WL). However, this technique has well-known drawbacks. Several wire-free techniques have been developed to overcome these drawbacks; one technique is localisation by Radiofrequency Identification (RFID). The purpose of this clinical trial was to assess the superiority of RFID tags (HOLOGIC) in terms of patient satisfaction, over wire localization of non-palpable breast lesions. Methods This was a single-centre, prospective, controlled and non-interventional trial. Patients were followed from their inclusion at the time of the preoperative consultation to the postoperative consultation, one month after surgery. Data on anxiety and satisfaction was collected from patients and clinicians using questionnaires, and clinical data was collected from the medical files. The primary outcome was the patients’ satisfaction scores, assessed using a visual analogue scale. Results Eighty patients were sequentially enrolled in two groups: the wire group (n = 40) and the RFID group (n = 40). One patient from the RFID group was excluded from the analysis because of a substantial migration during deployment. On a 10-point Visual Analogue Scale, the patients’ median satisfaction score was 9.8 (IQR = 1.32) for the wire group and 10 (IQR = 0.07) for the RFID group (p < 0.001). A reduction in pain between device insertion and surgery was observed in the RFID group (p = 0.009). The median placement time was shorter in the RFID group (15 min, IQR = 6) than in the wire group (20 min, IQR = 30) (p = 0.01). Conclusion Our results show a statistically significant difference in median patient satisfaction score with the localization of non-palpable breast cancer lesions using RFID tags compared to the use of the WL. Although our results did not show clinically significant outcomes in terms of satisfaction, RFID tags are a reliable alternative to WL and simplify the organization of patients’ healthcare trajectories. Trial registration ClinicalTrials.gov ID; NCT04750889 registered on February 11, 2021. https://clinicaltrials.gov/ct2/show/NCT04750889?term=rfid&draw=2&rank=1https://doi.org/10.1186/s12885-025-13453-0Breast cancerNon-palpable breast lesionsRadio-frequency tagWire-guided-localizationBreast conservation surgery
spellingShingle Raphaël Pete
Céleste Pinard
Fanny Sirodot
Ioana Molnar
Margot Dressaire
Angeline Ginzac
Catherine Abrial
Xavier Durando
Marielle Tekath
Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial
BMC Cancer
Breast cancer
Non-palpable breast lesions
Radio-frequency tag
Wire-guided-localization
Breast conservation surgery
title Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial
title_full Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial
title_fullStr Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial
title_full_unstemmed Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial
title_short Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial
title_sort patient satisfaction with radio frequency identification rfid tag localization compared with wire localization for nonpalpable breast lesions the rfid trial
topic Breast cancer
Non-palpable breast lesions
Radio-frequency tag
Wire-guided-localization
Breast conservation surgery
url https://doi.org/10.1186/s12885-025-13453-0
work_keys_str_mv AT raphaelpete patientsatisfactionwithradiofrequencyidentificationrfidtaglocalizationcomparedwithwirelocalizationfornonpalpablebreastlesionstherfidtrial
AT celestepinard patientsatisfactionwithradiofrequencyidentificationrfidtaglocalizationcomparedwithwirelocalizationfornonpalpablebreastlesionstherfidtrial
AT fannysirodot patientsatisfactionwithradiofrequencyidentificationrfidtaglocalizationcomparedwithwirelocalizationfornonpalpablebreastlesionstherfidtrial
AT ioanamolnar patientsatisfactionwithradiofrequencyidentificationrfidtaglocalizationcomparedwithwirelocalizationfornonpalpablebreastlesionstherfidtrial
AT margotdressaire patientsatisfactionwithradiofrequencyidentificationrfidtaglocalizationcomparedwithwirelocalizationfornonpalpablebreastlesionstherfidtrial
AT angelineginzac patientsatisfactionwithradiofrequencyidentificationrfidtaglocalizationcomparedwithwirelocalizationfornonpalpablebreastlesionstherfidtrial
AT catherineabrial patientsatisfactionwithradiofrequencyidentificationrfidtaglocalizationcomparedwithwirelocalizationfornonpalpablebreastlesionstherfidtrial
AT xavierdurando patientsatisfactionwithradiofrequencyidentificationrfidtaglocalizationcomparedwithwirelocalizationfornonpalpablebreastlesionstherfidtrial
AT marielletekath patientsatisfactionwithradiofrequencyidentificationrfidtaglocalizationcomparedwithwirelocalizationfornonpalpablebreastlesionstherfidtrial